New Chemical Entities (NCEs)
Not Specified
Not DisclosedActive
Key Facts
About Noucor Health
Noucor Health is a private, integrated pharmaceutical company with a long industrial heritage, now backed by MCH Private Equity and family offices. It combines R&D of novel drugs with a robust generics business and contract manufacturing services, operating across the entire value chain from API synthesis to finished product commercialization. With over 500 employees and a strong sustainability focus, the company aims to be a trusted strategic B2B partner in the global healthcare ecosystem. Its operations are split between a fine chemicals plant (Urquima) and facilities for pharmaceuticals and food supplements.
View full company profileOther Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| FL116 | Forlong Biotechnology | Not specified |
| FL117 | Forlong Biotechnology | Not specified |
| FL118 | Forlong Biotechnology | Not specified |
| FL301 | Forlong Biotechnology | Not specified |
| JSKN016 | AlphaMab Oncology | Phase 1 |
| JSKN033 | AlphaMab Oncology | Phase 1 |
| JSKN022 | AlphaMab Oncology | Phase 1 |
| JSKN027 | AlphaMab Oncology | Phase 1 |
| KN019 | AlphaMab Oncology | Phase 1 |
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| SR2162 | SIMR (Australia) Biotech | IND Approved |